To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT04893603
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Chengdu Silara Meditech Inc.
- Registry
-
NCT04893603
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT04893603. Allocation not applicable; no masking; primary purpose treatment. Start 2020-12-16 (actual); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- Transcatheter Aortic Valve System
- Lead sponsor
- Chengdu Silara Meditech Inc.
Record details
- Record id
cardio:ct-nct04893603- Content hash
510bbe0d5cbae6458eace9f7c7ef05d7ea1882c76999bec5eaac8d2682d7b5b2